UNSPSC 51151616: Atropine

This classification denotes an antimuscarinic agent with the molecular formula C17H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C0697DR9I, chemically known as 1alphah,5alphah-tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate but generally known as atropine, which bears US NIH Compound Identifier 3661.

UNSPSC 51151616 Atropine is a Commodity code that reflects state and local procurement of pharmaceutical products for emergency response and community health support. Based on recent solicitation activity, this code encompasses emergency medications and related medical supplies procured by county health departments and emergency management agencies to support opioid crisis response and public health initiatives. The issuing bodies soliciting under this code include county-level health and emergency services departments, which acquire these pharmaceuticals through competitive bidding processes for ongoing community health operations.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, and the contract included a two-year initial term with a one-year renewal option. Vendors were required to submit bids electronically, include all shipping and delivery costs, provide drug-free workplace certification and E-Verify compliance, and maintain workers' compensation and commercial general liability insurance. The procurement was potentially funded through FEMA and included federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act, with a three-month probationary period allowing Seminole County to terminate the agreement with or without cause.